FAQ Directory: HEDIS

Filter Results
  • Save

    Save your favorite pages and receive notifications whenever they’re updated.

    You will be prompted to log in to your NCQA account.

  • Email

    Share this page with a friend or colleague by Email.

    We do not share your information with third parties.

  • Print

    Print this page.

9.16.2024 New FDA approved blood test for Colorectal Cancer Screening measure (COL-E) Can an FDA approved blood test be used when reporting the COL-E measure?

The Colorectal Cancer Screening (COL-E) measure is based on the US Preventive Services Task Force (USPSTF) guidelines for colorectal cancer screening. The guidelines do not recommend serum (blood) testing (e.g., blood-based biomarker) and for this reason it does not meet criteria for the HEDIS measure. NCQA continually monitors clinical practice guidelines as they are updated.

HEDIS MY 2025

9.16.2024 PCS Questions Do answers from the Policy Clarification Support system have an expiration date?

Yes. Organizations may not use PCS responses that are over 3 years old. If your question relates directly to a measure specification or general guideline that was revised from a previous measurement year, submit the question rather than using the answer in PCS.

HEDIS MY 2025

9.16.2024 LTI Exclusion How can the LTI exclusion be identified?

Only the LTI flag in the Monthly Membership Detail Data File may be used when identifying this exclusion. No other data sources may be used.

HEDIS MY 2025

9.16.2024 Sampling for Glycemic Status Assessment for Patients With Diabetes (GSD), Eye Exam for Patients With Diabetes (EED), Blood Pressure Control for Patients With Diabetes (BPD) Measures For hybrid reporting, can the same sample be used for two measures (such as GSD and EED) and a different sample be used for another measure (BPD)?

Yes. Organizations may use the same sample for all measures, the same sample for two measures and a different sample for the third measure, or different samples for the three diabetes measures (GSD, EED, BPD).

HEDIS MY 2024

6.14.2024 RxNorm codes for Asthma Medication Ratio (AMR) Can RxNorm codes be used when identifying the required exclusion for members who had no asthma controller or reliever medications dispensed during the measurement year?

No. Although the Asthma Controller and Reliever Medication List includes RxNorm codes, they should not be used to identify dispensing events for this required exclusion. Only use pharmacy data (NDC codes) when assessing asthma controller or reliever medication dispensing events for this required exclusion. Because a dispensing event is required to calculate the numerator, members who had no dispensing events should be removed from the measure.

HEDIS MY 2024

5.21.2024 Inpatient Stay Value Set for Emergency Department Visits for Hypoglycemia in Older Adults with Diabetes (EDH) The HEDIS MY 2024 Value Set Directory (VSD) states that the Inpatient Stay Value Set was deleted from the EDH measure. Please clarify if it should be used for risk adjustment.

Yes, as described in the Guidelines for Risk Adjusted Utilization Measures, organizations must use the Inpatient Stay Value Set for the risk adjustment comorbidity category determination (use the Inpatient Stay Value Set to identify acute and nonacute inpatient discharges with a discharge date during the classification period). The value set was mistakenly deleted from the EDH measure in the VSD. Because the guidelines clearly state that the value set must be used, NCQA does not intend to reissue the VSD.

HEDIS MY 2024

5.15.2024 Direct reference code 76689-9 for Cervical Cancer Screening (CCS) LOINC code 76689-9 is included in the CCS measure specification but was deleted from CCS in the Value Set Directory (VSD). Please clarify if the code should be used when reporting Cervical Cancer Screening for MY 2024.

Yes, as described in the Required exclusions section of the CCS measure, use LOINC code 76689-9 to exclude members with a sex assigned at birth of male any time in the patient’s history. The code was mistakenly removed from the CCS measure in the 4-1-2024 release of the VSD (Direct Reference Code spreadsheet). Because the information needed for reporting is in the measure specification NCQA does not intend to reissue the VSD.

HEDIS MY 2024

5.15.2024 Direct Reference Codes Why are some codes included in the measure specification and not included in a value set?

When only a single code exists for a service or condition, it is included directly in the measure specification, and referred to as a Direct Reference Code (DRC). It is a best practice to not create value sets that include only a single code; some code systems prohibit this because it results in assigning another code (an OID) to a concept that already has a code.
DRCs are listed in the measure specifications and in a Direct Reference Codes spreadsheet in the value set directory.
For MY 2024, a number of single code value sets were converted to DRCs. The Summary of Changes – Value Sets spreadsheet indicates the value set was deleted. The Summary of Changes – Codes spreadsheet indicates the code was added as a DRC (filter Column A on “Direct Reference Code”).

HEDIS MY 2024

5.15.2024 eGFR and uACR Timing for Kidney Health Evaluation for Patients With Diabetes (KED) When does the “with service dates four days or less apart” specification apply?

The numerator criterion is an eGFR and a uACR any time during the measurement year. These separate tests may occur on different dates.
The 4-day proximity language is specific to a reporting option for uACR, where a quantitative urine albumin test and a urine creatinine test may be billed separately. In practice, the quantitative urine albumin and urine creatinine tests are performed on the same date, from the same urine sample, to produce a single ratio. The 4-day proximity language intends to account only for potential billing lags between the separate quantitative urine albumin and urine creatinine administrative codes that indicate a single uACR evaluation; it is not intended for separate samples from different dates.

HEDIS MY 2024

4.15.2024 SNS-E Numerator Criteria for Completed Screenings For screening indicators, which responses to screening questions meet numerator criteria?

Any coded response (i.e., any non-null response—positive or negative) on a pre-specified instrument for food, housing and transportation counts for completed screening numerators (numerators 1, 3, 5). The PRAPARE Food Insecurity Instrument question (LOINC code 93031-3) is an exception. Based on how the question is structured and responses are coded, a “No” or “None of the above” response cannot be coded and must be left null. Therefore, a null response meets criteria for this item only. 

HEDIS MY 2024

3.18.2024 HEDIS MY 2023 Audit Timeline Modifications Does the recent guidance issued by NCQA on HEDIS MY 2023 audit timeline modifications apply to all organizations?

No. If the medical record review retrieval and/or abstraction operations for HEDIS MY 2023 reporting of your organization were not impacted by the Change Healthcare cyberattack, then the timeline modifications do not apply to you. You must follow the HEDIS MY 2023 Audit Timeline published on NCQA.org.
Affected organizations (defined above) should work with their auditor on HEDIS MY 2023 timeline modifications. All HEDIS Compliance Audit Licensed Organizations will share this information with the relevant organizations.

 

HEDIS MY 2023

2.15.2024 Indication of an FOBT Test for the Colorectal Cancer Screening Measure Is documentation of “Colon Screening,” “Colon Screen” or “Colorectal Cancer Screening” sufficient to be considered an FOBT if it was completed during the measurement year?

Yes. Documentation of “Colon Screening,” “Colon Screen” or “Colorectal Cancer Screening,” with screening dates during the measurement year, could indicate an FOBT, the least invasive test that would use this limited documentation.

HEDIS MY 2023